MY ABPI LOGIN
 
Tags - ABPI statement

ABPI supports AMRC call to protect charity research

The AMRC and more than 30 top pharmaceutical and health tech companies have signed an open letter to the Prime Minister urging Government to provide financial support for medical research charities.

An open letter to: the BMJ

Earlier this week the British Medical Journal (BMJ) published and publicised a story which we believe inaccurately depicts the work of the pharmaceutical industry in the UK. Our chief executive Mike Thompson has written a letter to the BMJ in response.

Our view: Redistribution of UK’s portfolio of centrally authorised products

Last week, the EMA announced it has completed the reallocation of the medicines for which the UK's national regulator - the MHRA - is currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine.

UK pharma welcomes positive progression in Brexit talks

The Association of the British Pharmaceutical Industry (ABPI) - representing leading global pharmaceutical businesses in the UK - have welcomed the EU Council's agreement to progress Brexit negotiations to the next phase and the EU Council's approval of a transition period.

Attitudes towards pharma's role in health research

This week the Health Research Authority and National Institute for Health Research jointly published a report of the general public's attitudes towards health research. 
;